Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark
DGX agentarXiv:2606.30170v1 Announce Type: cross Abstract: Generative molecular design is shaped by simple proxy benchmarks for drug-like properties and models pretrained on large pharmaceutical datasets. This